Literature DB >> 36137075

The impact of Mendelian sleep and circadian genetic variants in a population setting.

Michael N Weedon1, Samuel E Jones1,2, Jacqueline M Lane3,4,5, Jiwon Lee6, Hanna M Ollila2,7,8,9, Amy Dawes1, Jess Tyrrell1, Robin N Beaumont1, Timo Partonen10, Ilona Merikanto10,11, Stephen S Rich12, Jerome I Rotter13,14, Timothy M Frayling1, Martin K Rutter15,16, Susan Redline6, Tamar Sofer6, Richa Saxena3,4,5, Andrew R Wood1.   

Abstract

Rare variants in ten genes have been reported to cause Mendelian sleep conditions characterised by extreme sleep duration or timing. These include familial natural short sleep (ADRB1, DEC2/BHLHE41, GRM1 and NPSR1), advanced sleep phase (PER2, PER3, CRY2, CSNK1D and TIMELESS) and delayed sleep phase (CRY1). The association of variants in these genes with extreme sleep conditions were usually based on clinically ascertained families, and their effects when identified in the population are unknown. We aimed to determine the effects of these variants on sleep traits in large population-based cohorts. We performed genetic association analysis of variants previously reported to be causal for Mendelian sleep and circadian conditions. Analyses were performed using 191,929 individuals with data on sleep and whole-exome or genome-sequence data from 4 population-based studies: UK Biobank, FINRISK, Health-2000-2001, and the Multi-Ethnic Study of Atherosclerosis (MESA). We identified sleep disorders from self-report, hospital and primary care data. We estimated sleep duration and timing measures from self-report and accelerometery data. We identified carriers for 10 out of 12 previously reported pathogenic variants for 8 of the 10 genes. They ranged in frequency from 1 individual with the variant in CSNK1D to 1,574 individuals with a reported variant in the PER3 gene in the UK Biobank. No carriers for variants reported in NPSR1 or PER2 were identified. We found no association between variants analyzed and extreme sleep or circadian phenotypes. Using sleep timing as a proxy measure for sleep phase, only PER3 and CRY1 variants demonstrated association with earlier and later sleep timing, respectively; however, the magnitude of effect was smaller than previously reported (sleep midpoint ~7 mins earlier and ~5 mins later, respectively). We also performed burden tests of protein truncating (PTVs) or rare missense variants for the 10 genes. Only PTVs in PER2 and PER3 were associated with a relevant trait (for example, 64 individuals with a PTV in PER2 had an odds ratio of 4.4 for being "definitely a morning person", P = 4x10-8; and had a 57-minute earlier midpoint sleep, P = 5x10-7). Our results indicate that previously reported variants for Mendelian sleep and circadian conditions are often not highly penetrant when ascertained incidentally from the general population.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36137075      PMCID: PMC9499244          DOI: 10.1371/journal.pgen.1010356

Source DB:  PubMed          Journal:  PLoS Genet        ISSN: 1553-7390            Impact factor:   6.020


  34 in total

1.  Cohort Profile: The National FINRISK Study.

Authors:  Katja Borodulin; Hanna Tolonen; Pekka Jousilahti; Antti Jula; Anne Juolevi; Seppo Koskinen; Kari Kuulasmaa; Tiina Laatikainen; Satu Männistö; Markku Peltonen; Markus Perola; Pekka Puska; Veikko Salomaa; Jouko Sundvall; Suvi M Virtanen; Erkki Vartiainen
Journal:  Int J Epidemiol       Date:  2018-06-01       Impact factor: 7.196

2.  Mutation of the Human Circadian Clock Gene CRY1 in Familial Delayed Sleep Phase Disorder.

Authors:  Alina Patke; Patricia J Murphy; Onur Emre Onat; Ana C Krieger; Tayfun Özçelik; Scott S Campbell; Michael W Young
Journal:  Cell       Date:  2017-04-06       Impact factor: 41.582

3.  The transcriptional repressor DEC2 regulates sleep length in mammals.

Authors:  Ying He; Christopher R Jones; Nobuhiro Fujiki; Ying Xu; Bin Guo; Jimmy L Holder; Moritz J Rossner; Seiji Nishino; Ying-Hui Fu
Journal:  Science       Date:  2009-08-14       Impact factor: 47.728

4.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

5.  Computationally efficient whole-genome regression for quantitative and binary traits.

Authors:  Joelle Mbatchou; Leland Barnard; Joshua Backman; Anthony Marcketta; Jack A Kosmicki; Andrey Ziyatdinov; Christian Benner; Colm O'Dushlaine; Mathew Barber; Boris Boutkov; Lukas Habegger; Manuel Ferreira; Aris Baras; Jeffrey Reid; Goncalo Abecasis; Evan Maxwell; Jonathan Marchini
Journal:  Nat Genet       Date:  2021-05-20       Impact factor: 38.330

6.  Mutations in Metabotropic Glutamate Receptor 1 Contribute to Natural Short Sleep Trait.

Authors:  Guangsen Shi; Chen Yin; Zenghua Fan; Lijuan Xing; Yulia Mostovoy; Pui-Yan Kwok; Liza H Ashbrook; Andrew D Krystal; Louis J Ptáček; Ying-Hui Fu
Journal:  Curr Biol       Date:  2020-10-15       Impact factor: 10.834

7.  Integrative genomics viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Wendy Winckler; Mitchell Guttman; Eric S Lander; Gad Getz; Jill P Mesirov
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

8.  A Cryptochrome 2 mutation yields advanced sleep phase in humans.

Authors:  Arisa Hirano; Guangsen Shi; Christopher R Jones; Anna Lipzen; Len A Pennacchio; Ying Xu; William C Hallows; Thomas McMahon; Maya Yamazaki; Louis J Ptáček; Ying-Hui Fu
Journal:  Elife       Date:  2016-08-16       Impact factor: 8.140

9.  Biological and clinical insights from genetics of insomnia symptoms.

Authors:  Jacqueline M Lane; Samuel E Jones; Deborah A Lawlor; Martin K Rutter; Michael N Weedon; Richa Saxena; Hassan S Dashti; Andrew R Wood; Krishna G Aragam; Vincent T van Hees; Linn B Strand; Bendik S Winsvold; Heming Wang; Jack Bowden; Yanwei Song; Krunal Patel; Simon G Anderson; Robin N Beaumont; David A Bechtold; Brian E Cade; Mary Haas; Sekar Kathiresan; Max A Little; Annemarie I Luik; Andrew S Loudon; Shaun Purcell; Rebecca C Richmond; Frank A J L Scheer; Barbara Schormair; Jessica Tyrrell; John W Winkelman; Juliane Winkelmann; Kristian Hveem; Chen Zhao; Jonas B Nielsen; Cristen J Willer; Susan Redline; Kai Spiegelhalder; Simon D Kyle; David W Ray; John-Anker Zwart; Ben Brumpton; Timothy M Frayling
Journal:  Nat Genet       Date:  2019-02-25       Impact factor: 38.330

10.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.